Industry reports
Editor highlights

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019

Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019

  • $ 4 795
  • Industry report
  • by Transparency Market Research
  • April 2014
  • 113 pages

Clinical trial management system (CTMS) is a software solution for proper management, storage and analysis of drugs associated clinical data. CTMS is primarily employed to manage large amount of data involved in a clinical trial including planning, preparation and reporting. CTMS also provides data to ...

Industries: Drug Discovery and Development | Countries: World, United States, South Korea, Europe, Asia, Poland, France, Germany, China

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability

  • $ 3 500
  • Industry report
  • by GBI Research
  • March 2014
  • 66 pages

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability Summary GBI Research, the leading business intelligence provider, has released its latest research, "Epilepsy Therapeutics in Asia Pacific Markets to ...

Industries: Therapy | Countries: World, China, Australia, India, Japan, Asia

Amoun Pharmaceutical Co. SAE (Symbol:BOARD (ORDERS MARKET) SWOT Analysis, Strategy, Revenues and Profits

Amoun Pharmaceutical Co. SAE (Symbol:BOARD (ORDERS MARKET) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • March 2014
  • 18 pages

Amoun Pharmaceutical Co. SAE (Amoun Pharmaceutical) is engaged in the manufacture and distribution of human and veterinary pharmaceutical products and nutritional supplements. The company primarily focuses on the manufacture and distribution of medical, pharmaceutical, chemical health food products ...

Industries: Pharmaceutical | Countries: Oman, United Arab Emirates, Yemen, Qatar, Kuwait, Bahrain, Tanzania, Sudan, Ghana, Asia

Pharsight Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharsight Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • February 2014
  • 17 pages

Summary Pharsight Corporation (Pharsight) is a pharmaceutical company. The company provides software products and scientific consulting services to pharmaceutical and biotechnological companies. It operates through its product segments, analysis, data management, reporting and reporting validation. Pharsight ...

Industries: Pharmaceutical | Countries: United States, World, Singapore, Asia

Invida Pharmaceutical Holdings Pte. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Invida Pharmaceutical Holdings Pte. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • February 2014
  • 20 pages

Summary Invida Pharmaceutical Holdings Pte. Ltd. (Invida) is a pharmaceutical company, based in Singapore. The company operates in commercializing differentiated pharmaceutical products in the Asia Pacific and healthcare markets worldwide. It offers pharmaceutical and healthcare marketing and sales services, ...

Industries: Pharmaceutical | Countries: Singapore, Indonesia, World, Asia

United Laboratories, Inc. SWOT Analysis, Strategy, Revenues and Profits

United Laboratories, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • February 2014
  • 21 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmaceutical | Countries: Asia, Sri Lanka, Singapore, Vietnam, Thailand, Taiwan, Myanmar, Malaysia, China, Cambodia

Tripos, L.P. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tripos, L.P. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • January 2014
  • 16 pages

Summary Tripos, L.P. (Tripos) is a healthcare technology company. The company designs, develops and markets scientific software products and services. Its products include D360, SYBYL-X suite, muse, benchware 3D explorer and tripos chemistry extensions for KNIME. The company serves for pharmaceutical, ...

Industries: Pharmaceutical | Countries: World, United States, Europe, Australia, Singapore, South Africa, Asia

Solasia Pharma K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Solasia Pharma K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • January 2014
  • 21 pages

Summary Solasia Pharma K.K. (Solasia Pharma) is a pharmaceutical company. The company develops and commercializes oncology therapies in China, Japan and Asian countries. Its product SP-01 is a transdermal system for patients receiving chemotherapy. This system delivers the anti-emetic and granisetron ...

Industries: Pharmaceutical | Countries: Japan, China, Asia, World

Y.S.P. Southeast Asia Holding Berhad (Symbol:YSPSAH) SWOT Analysis, Strategy, Revenues and Profits

Y.S.P. Southeast Asia Holding Berhad (Symbol:YSPSAH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • December 2013
  • 27 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Y.S.P. Southeast Asia Holding Berhad SWOT Analysis report provides ...

Industries: Over-the-counter Drug | Countries: Asia

Pharmaceuticals Asia - Industry Report

Pharmaceuticals Asia - Industry Report

  • $ 1 407
  • Industry report
  • by Plimsoll Publishing Ltd UK
  • December 2013
  • 1000 pages

Plimsoll's PHARMACEUTICALS (Asia) analysis is the most definitive and accurate study of the PHARMACEUTICALS (Asia) sector in 2013. The report (compiled in ENGLISH language) is split into two sections and uses both a written and graphical analysis - analysing the 1000 largest PHARMACEUTICALS (Asia) companies. ...

Industries: Pharmaceutical | Countries: Asia

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.